During the past decade, Carilion Gynecologic Oncology Associates conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Carilion Gynecologic Oncology Associates" #1 sponsor was "Gynecologic Oncology Group" with 6 trials, followed by "Carilion Clinic" with 2 trials sponsored, "Telik" with 2 trials sponsored, "Unither Pharmaceuticals" with 1 trials sponsored and "Ångstrom Pharmaceuticals" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Carilion Gynecologic Oncology Associates" #1 collaborator was "National Cancer Institute (NCI)" with 6 trials as a collaborator, "GlaxoSmithKline" with 1 trials as a collaborator, "SWOG Cancer Research Network" with 1 trials as a collaborator and "Sanofi" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Carilion Gynecologic Oncology Associates" are "Ovarian Cancer" (6 trials), "Fallopian Tube Cancer" (2 trials), "Ovarian Neoplasms" (2 trials), "Advanced Endometrial Adenocarcinoma, Stage III A, B, C" (1 trials) and "Cervical Cancer" (1 trials). Many other conditions were trialed in "Carilion Gynecologic Oncology Associates" in a lesser frequency.

Most popular intervention types in "Carilion Gynecologic Oncology Associates" are "Drug" (9 trials), "Procedure" (2 trials), "Biological" (1 trials), "Genetic" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "carboplatin" (2 trials), "paclitaxel" (2 trials), "Docetaxel and Carboplatin" (1 trials), "Doxorubicin HCl Liposome Injection" (1 trials) and "Liposomal Doxorubicin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Carilion Gynecologic Oncology Associates" are 12 trials for "Female" genders.

Currently, there are NaN active trials in "Carilion Gynecologic Oncology Associates". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Carilion Gynecologic Oncology Associates, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Carilion Gynecologic Oncology Associates, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".